Navigation Links
XTENT Announces Third Quarter 2008 Financial Results
Date:11/4/2008

d approximately $210,000 in expenses in connection with this workforce reduction including approximately $7,000 of non-cash expenses. All of these expenses were incurred during the third quarter of 2008. Average cost savings from the workforce reduction initiative, combined with other cost saving initiatives planned by the company, is anticipated to be approximately $1.3 million each month.

"We remain encouraged by the level of enthusiasm expressed for our Custom NX customizable drug eluting stent systems at this year's TCT," commented Gregory D. Casciaro, XTENT's President and Chief Executive Officer. "Discussions with physicians at TCT were very positive and reinforce our belief that practitioners are interested in customizable stent technology."

"We have realized our anticipated cost reductions during the third quarter of 2008 and expect this favorable spending profile to continue through the fourth quarter," said Casciaro. "The total loss from operations has decreased by $4.3 million in the quarter ended September 30, 2008 as compared to the quarter ended June 30, 2008."

About XTENT

XTENT, Inc. is a medical device company focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). CAD is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems are designed to enable the treatment of single lesions, long lesions and multiple lesions of varying lengths and diameters, in one or more arteries with a single device. Note: XTENT(R) Custom NX(R) DES Systems have not been approved for sale by any regulatory authority.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements in this press release regarding XTENT's business that are not h
'/>"/>

SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. XTENT Announces Second Quarter 2008 Financial Results and Business Progress
2. XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors
3. XTENT Announces CUSTOM I Data Receives Recognition from EuroIntervention
4. XTENT to Present at Cowen and Companys 28th Annual Health Care Conference
5. XTENT Announces 2007 Financial Results
6. New study shows extent of harmful human influences on global ecosystems
7. XTENT Announces 2007 Financial Results Conference Call
8. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
9. XTENT Announces Third Quarter 2007 Financial Results
10. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2008 and to Provide a Business Update
11. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... types of cancer sends the protein factories in our ... uncontrolled growth, new research suggests. , Scientists at The ... responsible for ratcheting up activity of the endoplasmic reticulum ... blocks cancer cells need to keep growing. , A ... the flow of messages to the endoplasmic reticulum telling ...
(Date:7/9/2014)... Researchers have found that fecal transplantation is effective and ... patients. This is the result of a study led ... for Women,s Gastrointestinal Medicine at The Women,s Medicine Collaborative. ... in advance of print in the American Journal ... C. diff , has increased to epidemic proportions ...
(Date:7/9/2014)... has been a sharp increase in the number of ... the online, interactive service that allows patients to view ... schedule appointments, and renew prescriptions. , Over a six-year ... each year increased five-fold, while the number of ... to a study by Dr. David Gerber , ...
(Date:7/9/2014)... National Institute of Allergy and Infectious Diseases (NIAID), ... launched an early-stage clinical trial of CRS3123, an ... difficile ( C. difficile ) infection. CRS3123 ... that inhibits C. difficile growth while sparing normal ... enroll up to 30 healthy men and women ...
(Date:7/9/2014)... , , , , , ... , , , , ... an SA80 assault rifle and the microphone is 50m downrange from the firer and approximately 30cm from the bullet... , ... , , , , , ... , , , , , ...
Breaking Medicine News(10 mins):Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7
... 1 The Unilens Vision Inc. (OTC Bulletin Board: UVICF) (TSX ... dividend of U.S. $0.09 per common share, payable February 26, ... on February 12, 2010 .   , "We are pleased to ... a annualized dividend rate of U.S. $0.36 per share provides ...
... College Dublin researchers could benefit young adults (aged 18-25 ... Nolan of Trinity College Dublin and St James,s Hospital, Dublin, ... Diabetes Care . The study findings demonstrate new ... which is the body,s decreased ability to respond to the ...
... innate interest in the new and different may help ... published by the American Psychological Association. In controlled experiments, ... got cocaine. Novelty could help break the ... many addicts with novelty-craving, risk-taking personalities, the authors said. ...
... health both before and after a major event like a ... of quitting have a positive effect as well? ... Aviv University, the largest and most comprehensive of its kind. ... attack has about the same positive effect as other major ...
... ... & Poor’s Rating Services have upgraded Scripps Health from an A+ to ... million in California Health Facilities Finance Authority revenue bonds. Proceeds from the ... Scripps Health’s various patient care facilities and will reimburse Scripps Health for ...
... Registration ... locations across the U.S. and Canada. , ... Madison, WI (PRWEB) February 1, 2010 -- Trek Bicycle, North America’s largest domestic ... mountain bike skills program today. Designed to help riders of all experience levels, particularly women, ...
Cached Medicine News:Health News:Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share 2Health News:New research on type 2 diabetes could benefit young adults with the condition 2Health News:Novelty lures rats from cocaine-paired settings, hinting at new treatments for recovering addicts 2Health News:Novelty lures rats from cocaine-paired settings, hinting at new treatments for recovering addicts 3Health News:Smoker alert: Information you can live with 2Health News:Fitch, Standard & Poor's Upgrade Scripps Health to AA-; Scripps to Issue $220 Million in Hospital Revenue Bonds 2Health News:Trek Bicycle Announces Title Sponsorship of 2010 Dirt Series 2Health News:Trek Bicycle Announces Title Sponsorship of 2010 Dirt Series 3
(Date:1/15/2014)... -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging ... China,s orthopedic instrument industry has seen rapid ... from 3.28 billion yuan in 2006 to 9.85 billion ...
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate of ... an at-the-market registered direct offering, led by a dedicated ... definitive purchase agreements with these investors pursuant to which ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: